[Triperygium wilfordii multiglucoside ameliorates kidney damage in diabetic rats by inhibiting the expressions of MBL and MASP2]

Ruiping Zhao,Weidong Chen,Baochao Chang,Ruichen Fan,Lei Liu,Yan Pan,Yaling Guo
Abstract:Objective To explore the effect of Triperygium wilfordii multiglucoside (TWM) on the expressions of mannose-binding lectin (MBL) and mannan-binding lectin serine peptidase 2 (MASP2) in the kidney of diabetic rats, and discuss the protective role of TWM in diabetic nephropathy and its possible mechanism. Methods Forty-five male SD rats were randomly assigned into model group (n=35) and normal control group (n=10). Rats in the normal control group were fed with regular diet, while those in the model group were fed with high-fat high-sugar diet and given an intraperitoneal injection of 40 mg/kg streptozotocin (STZ) six weeks later. The successfully induced type 2 diabetic rat models (n=33) were then randomized into DM group (n=16) and TWM treatment group (n=17) treated with TWM [10 mg/(kg.d)] for eight weeks. At the end of 14th week, the levels of blood sugar, 24-hour urine protein, serum creatinine and blood urea nitrogen were measured. Renal pathological changes were examined with PAS staining. MBL-A and MASP2 expressions were detected by immunohistochemistry in the renal tissues. The expressions of MBL1, MASP2, NF-κB and MCP-1 mRNAs were semi-quantified by real-time PCR. The expressions of MBL-A, MASP2, NF-κB and MCP-1 proteins were determined by Western blotting. Results Compared with the diabetic group, the levels of serum creatinine, blood urea nitrogen, 24-hour urine protein decreased, renal histopathology was improved, the expressions of MBL, MASP2, NF-κB and MCP-1 mRNAs and proteins were reduced in the TWM group. Correlation analysis showed that the expression of MBL was positively correlated with MASP2, NF-κB, MCP-1 and 24-hour urine protein. Conclusion MBL and MASP2 are over-expressed in the kidney of diabetic rats. TWM can ameliorate kidney damage in diabetic rats and delay the development of diabetic nephropathy by inhibiting the expressions of MBL and MASP2.
What problem does this paper attempt to address?